Trigyn Technologies Ltd. Submits Annual Secretarial Compliance Report for FY26
Trigyn Technologies Limited has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The company received in-principle approval for listing 4,50,000 ESOP shares. A minor delay in RPT disclosure for H1FY26 led to a ₹5,900 fine from BSE and NSE.
The announcement is a routine compliance filing. While it mentions an ESOP approval, the core of the news is the secretarial compliance report, which has a low direct impact on the company's operations or financials.
The report is largely positive, confirming compliance with various SEBI regulations. However, a noted delay in RPT disclosure and a resulting fine prevent a fully positive sentiment.
Trigyn Technologies Limited has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026, as mandated by Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report, issued by M/s. VKM & Associates, Practicing Company Secretaries, confirms the company's compliance with applicable statutory provisions and good corporate practices during the review period.
The review covered compliance with the SEBI Act, 1992, and the Securities Contracts (Regulation) Act, 1956, along with various SEBI regulations including LODR, ICDR, SAST, Buy-back, Share Based Employee Benefits, NCS, PIT, Depositories, and RTA regulations. The company has adopted and updated applicable policies, maintains a functional website with timely dissemination of information, and has no disqualified directors.
During the review period, Trigyn Technologies Limited received in-principle approval from BSE Limited and the National Stock Exchange of India Limited for the listing of 4,50,000 equity shares to be issued under its Employee Stock Option Plan 2025. The report also noted that the company has identified material subsidiary companies and complied with disclosure requirements for both material and other subsidiaries. Preservation of documents, performance evaluation of the board and committees, and adherence to related party transaction approvals were also confirmed.
One instance of non-compliance was noted: a delay in the submission of the Related Party Transactions (RPT) disclosure for the half-year ended September 30, 2025, resulting in a fine of ₹5,900 each from BSE and NSE, which has been paid by the company. The delay was attributed to procedural reasons. The company has also confirmed that no actions were taken against it by SEBI or stock exchanges during the review period, and it has maintained proper records as per SEBI regulations.
What to do with a filing like this
Trigyn Technologies Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Trigyn Technologies Limited. Read the original for the full detail.